Monterey Bio Acquisition Corp (MTRYU): Price and Financial Metrics
MTRYU Price/Volume Stats
Current price | $10.41 | 52-week high | $11.09 |
Prev. close | $10.95 | 52-week low | $10.10 |
Day low | $10.41 | Volume | 100 |
Day high | $10.41 | Avg. volume | 1,129 |
50-day MA | $10.26 | Dividend yield | N/A |
200-day MA | $0.00 | Market Cap | N/A |
MTRYU Stock Price Chart Interactive Chart >
Monterey Bio Acquisition Corp (MTRYU) Company Bio
Monterey Bio Acquisition Corporation focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to acquire businesses in the biotech industry. The company was formerly known as Chardan FinTech Acquisition Corp. and changed its name to Monterey Bio Acquisition Corporation in April 2021. Monterey Bio Acquisition Corporation was incorporated in 2020 and is based in New York, New York.
Latest MTRYU News From Around the Web
Below are the latest news stories about Monterey Bio Acquisition Corp that investors may wish to consider to help them evaluate MTRYU as an investment opportunity.
Monterey Bio Acquisition Corporation Announces Closing of Initial Public Offering and Full Exercise of Underwriter's Option to Purchase Additional UnitsMonterey Bio Acquisition Corporation ("Monterey Bio" or the "Company") (Nasdaq: MTRYU) today announced the closing of its previously announced initial public offering of 10,000,000 units, at a price to the public of $10.00 per unit. The Company also announced that the underwriter had exercised in full its option to purchase 1,500,000 additional units, with the option expected to close on October 6, 2021, subject to customary closing conditions. Each unit consists of one share of common stock and |
MTRYU Price Returns
1-mo | N/A |
3-mo | N/A |
6-mo | N/A |
1-year | N/A |
3-year | N/A |
5-year | N/A |
YTD | N/A |
2022 | N/A |
2021 | N/A |
2020 | N/A |
2019 | N/A |
2018 | N/A |
Loading social stream, please wait...